Condensed Balance Sheets - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 150,000	$ 156,000
Accounts receivable, net of allowance for doubtful accounts of $51,000 at September 30, 2017 and $49,000 at December 31, 2016	521,000	556,000
Inventory, net of allowance of $453,000 at September 30, 2017 and $449,000 at December 31, 2016	1,462,000	1,582,000
Prepaid expenses and other current assets	49,000	92,000
Total current assets	2,182,000	2,386,000
Property, plant and equipment, net	810,000	824,000
Patents, net	107,000	93,000
Other assets	21,000	21,000
Deferred finance costs - line of credit, net	23,000	47,000
Total assets	3,143,000	3,371,000
Current liabilities
Accounts payable	306,000	304,000
Accrued expenses and other current liabilities	287,000	276,000
Wages payable	257,000	299,000
Line of credit	580,000	639,000
Current portion of long-term debt	87,000	75,000
Total current liabilities	1,517,000	1,593,000
Long-term debt, net of current portion and deferred finance costs	748,000	753,000
Other long-term liabilities	22,000	0
Total liabilities	2,287,000	2,346,000
COMMITMENTS AND CONTINGENCIES
Stockholders' equity:
Preferred stock; par value $.01 per share; 5,000,000 shares authorized, none issued and outstanding at September 30, 2017 and December 31, 2016	0	0
Common stock; par value $.01 per share; 50,000,000 shares authorized; 29,297,333 issued and outstanding at September 30, 2017 and 28,842,788 issued and outstanding at December 31, 2016	293,000	288,000
Additional paid-in capital	21,115,000	21,037,000
Accumulated deficit	(20,552,000)	(20,300,000)
Total stockholders’ equity	856,000	1,025,000
Total liabilities and stockholders’ equity	$ 3,143,000	$ 3,371,000